Predictors of prostate cancer detection using an extended biopsy regimen in patients with a total PSA between 2.5 and 4.0ng/ml

被引：0
|
作者：
Stephenson, AJ
Singh, H
Canto, EI
Shariat, SF
Kattan, MW
Scardino, PT
Kadmon, D
Miles, BJ
Wheeler, TM
Slawin, KM
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)37901-1
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Proenzyme PSA for the early detection of prostate cancer in the 2.5-4.0 ng/ml total PSA range: Preliminary analysis
    Sokoll, LJ
    Chan, DW
    Mikolajczyk, SD
    Rittenhouse, HG
    Evans, CL
    Linton, HJ
    Mangold, LA
    Mohr, P
    Bartsch, G
    Klocker, H
    Horninger, W
    Partin, AW
    UROLOGY, 2003, 61 (02) : 274 - 276
  • [2] Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population
    Kobayashi, T
    Nishizawa, K
    Mitsumori, K
    Ogura, K
    Ide, Y
    JOURNAL OF UROLOGY, 2004, 171 (04): : 478 - 479
  • [3] Predictors of subsequent prostate cancer in men with a PSA level of 2.6-4.0 ng/ml and an initially negative biopsy
    Eggener, SE
    Roehl, KA
    Han, M
    Catalona, WJ
    JOURNAL OF UROLOGY, 2005, 173 (04): : 396 - 396
  • [4] PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml
    Djavan, B
    Zlotta, A
    Kratzik, C
    Remzi, M
    Seitz, C
    Schulman, CC
    Marberger, M
    UROLOGY, 1999, 54 (03) : 517 - 522
  • [5] DOES A SECOND CONFIRMATORY PSA ABOVE 4.0NG/ML LEAD TO THE DIAGNOSIS OF MORE CLINICALLY SIGNIFICANT PROSTATE CANCER?
    Werntz, Ryan
    Stoller, Wesley
    Garzotto, Mark
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1081 - E1081
  • [6] The clinic-pathological characteristics of prostate cancer in an Irish subpopulation with a serum PSA less than 4.0ng/ ml
    O'Kelly, F.
    McGuire, B. B.
    Flynn, R. J.
    Grainger, R.
    McDermott, T. E. D.
    Thornhill, J. A.
    JOURNAL OF CLINICAL UROLOGY, 2014, 7 (05) : 338 - 343
  • [7] The diagnostic impact of pro-PSA in the early detection of prostate cancer (PCA) in patients with a total PSA range of 4.0 to 10.0 ng/ml
    Veltri, RW
    Khan, MA
    Rittenhouse, HG
    Mikolajczyk, SD
    Sokoll, LJ
    Chan, DW
    Partin, AW
    JOURNAL OF UROLOGY, 2003, 169 (04): : 384 - 384
  • [8] Diagnostic yield of a PSA threshold for prostate biopsy of 2.5 ng/ml compared to 4 ng/ml
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 237 - 237
  • [9] Diagnostic yield of a PSA threshold for prostate biopsy of 2.5 ng/ml compared to 4 ng/ml
    Muntener, M
    Kunz, U
    Eichler, K
    Puhan, M
    Schmid, DM
    Jaeger, P
    Strebel, RT
    JOURNAL OF UROLOGY, 2006, 175 (04): : 480 - 480
  • [10] Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0?ng/ml
    Lucarelli, Giuseppe
    Fanelli, Margherita
    Larocca, Angela Maria Vittoria
    Germinario, Cinzia Annatea
    Rutigliano, Monica
    Vavallo, Antonio
    Selvaggi, Francesco Paolo
    Bettocchi, Carlo
    Battaglia, Michele
    Ditonno, Pasquale
    PROSTATE, 2012, 72 (15): : 1611 - 1621
12345